STAT3-Luc/EF1α-mCherry Reporter Cell Line - NIH3T3

The STAT3-Luc/EF1α-mCherry reporter cell line (based on NIH3T3) is a stably engineered mouse fibroblast cell line designed for the sensitive monitoring of STAT3 transcriptional activity. Derived from NIH3T3 cells, this reporter line incorporates a luciferase reporter cassette regulated by STAT3-responsive elements, enabling the quantitative analysis of pathway activation via luminescence detection. Concurrently, the constitutive expression of mCherry—driven by the EF1α promoter—provides a reliable fluorescent marker for cell identification, data normalization, and the monitoring of cell number or transduction stability. STAT3 is a key transcription factor activated downstream of cytokines, growth factors, and inflammatory mediators, primarily through a JAK-dependent phosphorylation process. Upon activation, STAT3 forms dimers and translocates into the nucleus, where it regulates genes involved in cell proliferation, survival, immune responses, inflammation, and tissue remodeling. This dual-reporter design combines a functional pathway readout with a convenient red fluorescent selection marker, offering a robust platform for experimental development within a well-characterized fibroblast background.

This cell line is suitable for screening and characterizing compounds that modulate the JAK/STAT3 signaling axis. It can be used to assess STAT3 activation induced by cytokines (such as members of the interleukin-6 family), analyze dose-response relationships, and determine the potency of pathway inhibitors, neutralizing antibodies, kinase inhibitors, or other bioactive substances. The luciferase signal serves as a rapid, scalable endpoint readout for high- or medium-throughput screening, while the mCherry fluorescence facilitates imaging-based analysis, culture quality control, cell tracking, and data normalization across various experimental conditions. Furthermore, this reporter cell line can be employed to investigate mechanisms underlying inflammatory signaling, the regulation of oncogenic pathways, fibrosis-related responses, and the crosstalk between STAT3 and other cellular signaling networks. At the same time, it can also be used to validate gene-editing strategies, RNA interference experiments, and receptor-targeting studies, as well as for the functional testing of engineered cytokines or biological agents.